Getting would-be investors—and the right kind of investors—to notice and care about your company requires a robust strategy.

The post Navigating the Tricky Climate of Health Tech Funding appeared first on MedCity News.

Transcarent recently announced that it raised $126 million in Series D funding led by General Catalyst and 7wireVentures. When asked what his exit strategy is, CEO Glen Tullman said he does not want to sell Transcarent, but sees an initial public offering as an option.

The post Glen Tullman Has ‘No Interest’ In Selling Transcarent, But IPO Is a Possibility appeared first on MedCity News.

Digital health companies have now raised more than $20 billion in 2021, more than any other year. While experts expect to see the dealmaking continue, they raised caution about the challenges of going public with high valuations. 

The post Digital health funding smashed another record this year, but is the trend sustainable? appeared first on MedCity News.

The startup is developing digital therapeutics that use cognitive behavioral therapy-based programs to address cardiometabolic conditions. It began trading on Nasdaq on Friday.

The post Better Therapeutics goes public through SPAC, will put proceeds toward first digital therapeutic appeared first on MedCity News.

The company, which provides revenue cycle management solutions for providers, is filing for the IPO less than two years after Bon Secours Mercy Health sold its majority stake in Ensemble to private equity firm Golden Gate Capital. Per the filing, the company aims to raise $100 million, but that is likely a placeholder figure.

The post With 5 patents under its belt, RCM tech company Ensemble Health Partners files for IPO appeared first on MedCity News.

The diagnostics company currently has an authorized at-home Covid-19 test, and plans to expand into flu tests and other diagnostics. After pricing its stock at $16 per share, it climbed to $20 on Friday.

The post Portable diagnostics company Cue raises $200M in IPO appeared first on MedCity News.

The San Diego-based company began marketing its first product, a portable Covid-19 test, after receiving an emergency use authorization last year. Now, it’s filing the initial paperwork to go public as it scales up manufacturing. 

The post Buoyed by Covid-19 tests, Cue files for IPO  appeared first on MedCity News.

Bright Health will use proceeds from its IPO to fund the expansion, which will bring its total number of markets to 141 from 99. The company will also expand its product portfolio in states where it already operates.

The post Bright Health to grow footprint in 2022, adding 42 new markets appeared first on MedCity News.

Everside Health Group, a Denver-based direct primary care startup, filed to go public. The company was formed out of a merger between three primary care groups, and primarily works with self-insured employers.

The post Denver-based direct primary care startup files to go public  appeared first on MedCity News.

The social network for physicians recently went public in an upsized IPO that valued the company at about $4.6 billion. With many physicians already on the platform, chief strategy officer Dr. Nate Gross shared the company’s plans for future growth. 

The post Doximity’s stock doubles after IPO. Here’s how it plans to keep the momentum going. appeared first on MedCity News.

Digital therapeutics startup Pear Therapeutics struck a deal to go public through a blank-check acquisition that would value the company at $1.6B. But it still faces big challenges in selling its app-based treatments. 

The post Pear Therapeutics plans to go public in $1.6B SPAC deal appeared first on MedCity News.

With plans to sell 60 million shares of common stock, Bright Health will price its IPO between $20 and $23 per share. It will trade on the New York Stock Exchange under the symbol “BHG,” according to a recent SEC filing.

The post Bright Health sets terms for $1.3B IPO  appeared first on MedCity News.

In Venrock’s annual survey of healthcare leaders, respondents expected most digital health startups that went public during the pandemic to see their valuations fall by the end of the year. 

The post  Bloom is off the health tech IPO rose, as valuations expected to fall  appeared first on MedCity News.

Doximity, the “LinkedIn for physicians,” is preparing for an IPO. In an unusual move, it’s setting aside a portion of its shares for some of its users.

The post Doximity carves out a portion of IPO for physician users appeared first on MedCity News.

Bright Health has filed preliminary paperwork for an IPO, joining its rivals in the insurance technology space in going public. Though there are few confirmed details at the moment, Bright Health is reportedly looking to raise $1 billion through the offering.

The post Bright Health follows rival Oscar Health down IPO path appeared first on MedCity News.

Vera Therapeutics raised $47.9 million from its IPO to continue clinical development of its lead asset, a potential treatment for the kidney disease IgA nephropathy. But the company is joining a crowded field of companies aiming to develop a drug for the rare disorder.

The post Wall Street is lukewarm to Vera’s pivot from gene editing to rare kidney disease appeared first on MedCity News.

In a wide-ranging interview, Privia Health CEO Shawn Morris discussed the company’s recently closed IPO, its plans for the funds raised and what he sees as the company’s biggest value-add as the Covid-19 pandemic enters a new phase.

The post Privia Health CEO: IPO allows us to be independent & purely focused on strategy appeared first on MedCity News.

The physician practice management company launched its IPO through which it plans to sell 19.5 million shares of common stock, priced between $17 and $19 per share. It will use the proceeds for general corporate purposes, like research and development, and to acquire complementary businesses or technologies.

The post Privia Health launches IPO, aims to raise up to $370M appeared first on MedCity News.

VillageMD, a primary care startup that has Walgreens as a big backer, is reportedly planning to go public. The company has plans to open hundreds of co-located primary care clinics at Walgreens pharmacies. 

The post Report: Walgreens-backed primary care startup planning IPO appeared first on MedCity News.

Insurance startup Bright Health is reportedly planning to raise up to $1 billion in an IPO that will be launched in the second quarter of 2021. The company, which provides several insurance products as well as an IT platform, could be valued at more than $10 billion, Bloomberg reported.

The post Report: Bright Health eyes $1B IPO appeared first on MedCity News.

Peter Meath, J.P. Morgan Commercial Banking’s Co-Head of Healthcare and Life Sciences, applies lessons from 2020’s remarkable second half and shares insights on what to expect in 2021.

The post J.P. Morgan’s life sciences outlook for 2021 appeared first on MedCity News.

Alignment Healthcare, an insurtech startup, has launched its IPO and plans to price its individual shares between $17 and $19. The company offers Medicare Advantage plans and says it uses predictive analytics technology to pinpoint seniors’ care needs.

The post Alignment Healthcare aims to raise up to $516M in IPO appeared first on MedCity News.

Insurance startup Alignment Healthcare filed preliminary paperwork with the Securities and Exchange Commission to go public. It’s another healthcare startup that is banking on the value of its technology in an IPO.

The post Four takeaways from Alignment’s IPO filing appeared first on MedCity News.

Insurance startup Oscar Health plans to price its IPO between $32 and $34 per share.  The New York-based startup plans to trade on the New York Stock Exchange under the ticker “OSCR.”

The post Oscar Health looks to raise $1B in IPO appeared first on MedCity News.

Digital health startup Sharecare plans to go public through a merger with a blank-check company created by Alan Mnuchin. The deal will value the company at $3.9 billion.

The post Sharecare confirms plans to go public through SPAC merger appeared first on MedCity News.

Signify Health, a company that provides services for value-based care programs, went public on Thursday in an upsized IPO. The company’s stock began trading at $24 per share, above its expected range of $20 to $21 per share.

The post Signify Health goes public in upsized IPO appeared first on MedCity News.

Consumer DNA testing company 23andMe plans to go public through a merger with a special-purpose acquisition company started by Virgin Group. As sales of DNA testing kits wane, how will 23andMe drum up new interest for its business?

The post 4 takeaways from 23&Me’s planned SPAC deal appeared first on MedCity News.

Sana Biotechnology is turning new science into novel medicines intended to overcome limitations of current cell therapies. After going from stealth to IPO in two years, it’s now planning to bring multiple programs into clinical testing in 2022.

The post Sana Bio soars in stock market debut, raising $588M for cell & gene therapies appeared first on MedCity News.

Direct-to-consumer health startup Ro is reportedly in talks go public through a merger with a blank-check company, according to a report by Reuters.

The post Report: Ro in talks to go public through blank-check merger appeared first on MedCity News.

Sharecare, a digital health startup created by Web MD founder Jeff Arnold and Dr. Mehmet Oz, is reportedly in talks to go public through a merger with a special-purpose acquisition company. It also recently acquired startup Doc.ai.

The post Sharecare acquires Doc.ai, reportedly plans to go public via SPAC appeared first on MedCity News.